Neuro3 Therapeutics Secures Exclusive License Deal with Lundbeck for KCNQ2 Activator Programs
Neuro3 Therapeutics (Neuro3), a biotechnology company specializing in central nervous system (CNS) diseases with operations...
Deals
Acorda Therapeutics Strikes Deal with Hangzhou Chance for Inbrija Distribution in China
US-based Acorda Therapeutics Inc., (Nasdaq: ACOR) has announced a distribution and supply agreement with Hangzhou...
EQRx Inc. Abandons Plans for Low-Cost Drugs, Terminates Development of Three China-Sourced Products
US-based biotech EQRx Inc., (Nasdaq: EQRX) has disclosed in its Q4 2022 financial report a...
Shunxi Holding Group Secures Licensing Deal for Cartherics’ CTH-004 in Greater China
China-based Shunxi Holding Group Co. Ltd has entered into a licensing deal with Australia-based firm...
Shenzhen’s Angio8 Secures Tens of Millions in Series A Financing for Surgical Robot Development
Angio8, a Shenzhen-based developer of vascular interventional surgical robots, has reportedly raised tens of millions...
Sinopharm Partners with Fudan University to Establish National Innovation Platform
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Fudan...
Lingyi Biotechnology Secures RMB 100 Million in Series A Funding for Gene Therapy Pipeline
China-based gene therapy developer Lingyi Biotechnology Co., Ltd has reportedly raised close to RMB 100...
Shanghai Junshi Biosciences Inks Exclusive License Deal with Dr. Reddy’s Laboratories for Tuoyi
Shanghai Junshi Biosciences Co., Ltd (SHA: 688180), a China-based biotechnology firm, has announced an exclusive...
Sinopharm Partners with Shenzhen to Boost High-End Medical Device and Pharmaceutical Innovation
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Shenzhen...
XtalPi Inc. and China Pharmaceutical University Launch Joint AI Research Center in China
Sino-US artificial intelligence (AI) firm XtalPi Inc. has joined forces with China Pharmaceutical University (CPU)...
Hasten Biopharm Acquires Commercial Rights to Rocephin in China from Roche
China-based Hasten Biopharmaceutical Co., Ltd has announced the acquisition of the commercial rights in China...
VivaVision Biotech Secures Over RMB 100 Million in Series D2 Financing for Ophthalmology Pipeline Expansion
China’s VivaVision Biotech Inc. has announced the successful completion of its Series D2 financing round,...
Kangrui Health Partners with West China Second University Hospital for Pediatric Care Innovation
Kangrui Health, a leading data and intelligence application company based in Beijing, has entered into...
Medisan Pharmaceutical Secures PPAR Agonist Technology from China Pharmaceutical University
Harbin Medisan Pharmaceutical Co., Ltd (SHE: 002900) has announced a significant patent and technology transfer...
NeuExcell Therapeutics Secures Over $14.5 Million in Pre-Series A+ Funding for Neurological Treatments
NeuExcell Therapeutics, a Sino-US biotech company specializing in treatments for neurological damage and degenerative diseases,...
Cellular Biomedicine Group Inc. and Janssen Biotech, Inc. Announce Global Collaboration for CAR-T Therapies
China-based cell therapy specialist Cellular Biomedicine Group Inc. (CBMG), emerging from a merger deal in...
Johnson & Johnson’s Kenvue IPO Raises USD 3.8 Billion, Marking Year’s Largest US IPO
US healthcare giant Johnson & Johnson (J&J, NYSE: JNJ) has announced the initial public offering...
Reforgene Medicine Secures Pre-Series B Funding to Advance Thalassemia Gene Therapy
Reforgene Medicine, a Guangzhou-based gene editing therapy company, has reportedly secured hundreds of millions of...
Zai Lab Partners with MediLink Therapeutics to Develop YL212 DLL3 ADC
Zai Lab Limited (NASDAQ: ZLAB, HKG: 9688), a China-based biopharmaceutical company, has announced a strategic...
OBiO Technology and ImmVira Partner on Oncolytic Virus Project for BLA Filing and Commercialization
OBiO Technology (Shanghai) Co., Ltd (SHA: 688238), a leading gene therapy specialist based in China,...